United States · FDA National Drug Code directory
Dalfampridine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82249-702_c40dcc84-b839-44aa-94f2-886fb1c3d75c
- Product NDC
- 82249-702
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Dalfampridine
- Labeler
- CivicaScript LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250721
- Source listing expiry
- 20261231
Source-listed ingredients
- DALFAMPRIDINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (82249-702-60) · 82249-702-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →